Providence Capital Advisors’s Clorox CLX Stock Holding History

Providence Capital Advisors’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-50	Closed	-$10K	–	313
2021 Q1	$10K	Hold	50	–	–	﹤0.01%	205
2020 Q4	$10K	Buy	+50	New	+$10.3K	﹤0.01%	215

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CRC

Cedar Rock Capital London, United Kingdom $4.05B AUM 21.89% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Providence Capital Advisors's CLX Position: Q2 2021 in Review

Providence Capital Advisors sold out of Clorox (CLX) in Q2 2021, closing a stake of 50 shares — an estimated $10K sold.

Providence Capital Advisors first reported a position in CLX in Q4 2020 and held it in 2 quarters. The position peaked at $10K in Q1 2021. 1,168 funds tracked by Wall St. Rank hold CLX as of Q2 2021.

Providence Capital Advisors reported no remaining Clorox position as of Q2 2021 after selling out during the quarter.
Providence Capital Advisors sold 50 Clorox shares in Q2 2021, an estimated $10K.
Providence Capital Advisors first reported a position in Clorox in Q4 2020 and held it in 2 quarters.
Providence Capital Advisors's Clorox position peaked at $10K in Q1 2021.
1,168 funds tracked by Wall St. Rank held Clorox as of Q2 2021.

Based on Providence Capital Advisors's 13F filing for Q2 2021, filed 9 Aug 2021.